Plasma thioredoxin, a novel oxidative stress marker, in patients with obstructive sleep apnea before and after nasal continuous positive airway pressure

Antioxidants and Redox Signaling

Volumn 10, Issue 4, 2008, Pages 715-726

  Takahashi, Ken Ichi ^a   Chin, Kazuo ^a   Nakamura, Hajime ^b   Morita, Satoshi ^a   Sumi, Kensuke ^a   Oga, Toru ^a   Matsumoto, Hisako ^a   Niimi, Akio ^a   Fukuhara, Shunichi ^a   Yodoi, Junji ^b   Mishima, Michiaki ^a  

^a KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 6; THIOREDOXIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; MORTALITY; OXIDATIVE STRESS; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; SLEEP APNEA SYNDROME;

ADIPONECTIN; ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CONTINUOUS POSITIVE AIRWAY PRESSURE; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; OXIDATIVE STRESS; POLYSOMNOGRAPHY; SLEEP APNEA, OBSTRUCTIVE; THIOREDOXINS;

OSA;

EID: 38949207976     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2007.1949     Document Type: Article

References (43)

1. American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research: the report of an American Academy of Sleep Medicine Task Force. Sleep 14: 540-545, 1999.
2. Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, Hotta K, Shimomura I, Nakamura T, Miyaoka K, Kuriyama H, Nishida M, Yamashita S, Okubo K, Matsubara K, Muraguchi M, Ohmoto Y, Funahashi T, and Matsuzawa Y. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257: 79-83, 1999.
3. Barcelo A, Barbe F, de la Pena M, Vila M, Perez G, Pierola J, Duran J, and Agusti AG. Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment. Eur Respir J 27: 756-760, 2006.
4. Chin K, Shimizu K, Nakamura T, Narai N, Masuzaki H, Ogawa Y, Mishima M, Nakamura T, Nakao K, and Ohi M. Change in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 100: 706-712, 1999.
5. Christou K, Moulas AN, Pastaka C, and Gourgoulianis KI. Antioxidant capacity in obstructive sleep apnea patients. Sleep Med 4: 225-228, 2003.
6. Dhalla NS, Temsah RM, and Netticadan T. Role of oxidative stress in cardiovascular diseases. J Hypertens 18: 655-673, 2000.
7. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, and Shimomura I. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114: 1752-1761, 2004.
8. Guilleminault C, Kirisoglu C, and Ohayon MM. C-reactive protein and sleep-disordered breathing. Sleep 27: 1507-1511, 2004.
9. Harsch IA, Wallaschofski H, Koebnick C, Schahin SP, Hahn EG, Ficker JH, and Lohmann T. Adiponectin in patients with obstructive sleep apnea syndrome: course and physiological relevance. Respiration 71: 580-586, 2004.
10. Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, Iwahashi H, Kiriyama H, Ouchi N, Maeda K, Nishida M, Kihara S, Sakai N, Nakajima T, Hasegawa K, Muraguchi M, Ohmoto Y, Nakamura T, Yamashita S, Hanafusa T, and Matsuzawa Y. Plasma concentrations of novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20: 1595-1599, 2000.
11. Ip MS, Lam B, Ng MM, Lam WK, Tsang KW, and Lam KS. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 165: 670-676, 2002.
12. Kishimoto C, Shioji K, Nakamura H, Nakayama Y, Yodoi J, and Sasayama S. Serum thioredoxin (TRX) levels in patients with heart failure. Jpn Circ J 65: 491-494, 2001.
13. Kondo N, Ishii Y, Kwon YW, Tanito M, Hirota H, Nishinaka Y, Nakamura H, and Yodoi J. Redox-sensing release of human thioredoxin from T lymphocytes with negative feedback loops. J Immunol 172: 442-448, 2004.
14. Lavie L. Obstructive sleep apnoea syndrome: an oxidative stress disorder. Sleep Med Rev 7: 35-51, 2002.
15. Lavie L, Vishnevsky A, and Lavie P. Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 27: 123-128, 2004.
16. Lindmark E, Diderholm E, Wallentin L, and Siegbahn A. Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease: effects of an early invasive or noninvarive strategy. JAMA 286: 2107-2113, 2001.
17. Marin JM, Carrizo SJ, Vicente E, and Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365: 1046-1053, 2005.
18. Matsuda M, Shimomura I, Sata M, Arita Y, Nishida M, Maeda N, Kumada M, Okamoto Y, Nagaretani H, Nishizawa H, Kishida K, Komuro R, Ouchi N, Kihara S, Nagai R, Funahashi T, and Matsuzawa Y. Role of adiponectin in preventing vascular stenosis: the missing link of adipo-vascular axis. J Biol Chem 277: 37487-37491, 2002.
19. Matsuzawa Y, Funahashi T, and Nakamura T. Molecular mechanism of metabolic syndrome X: contribution of adipocytokines adipocyte-derived bioactive substances. Ann N Y Acad Sci 892: 146-154, 1999.
20. Miwa K, Kishimoto C, Nakamura H, Makita T, Ishii K, Okuda N, Yodoi J, and Sasayama S. Serum thioredoxin and á-tocopherol concentrations in patients with major risk factors. Circ J 69: 291-294, 2005.
21. Miyamoto S, Kawano H, Takazoe K, Soejima H, Sakamoto T, Hokamaki J, Yoshimura M, Nakamura H, Yodoi J and Ogawa H. Vitamin E improves fibrinolytic activity in patients with coronary spastic angina. Thromb Res 113: 345-351, 2004.
22. Miyamoto S, Sakamoto T, Soejima H, Shimomura H, Kajiwara I, Kojima S, Hokamaki J, Sugiyama S, Yoshimura M, Ozaki Y, Nakamura H, Yodoi J, and Ogawa H. Plasma thioredoxin levels and platelet aggregability in patients with acute myocardial infarction. Am Heart J 146: 465-471, 2003.
23. Nakamura H. Thioredoxin and its related molecules: update 2005. Antioxid Redox Signal 7: 823-828, 2005.
24. Nakamura H, Herzenberg LA, Bai J, Araya S, Kondo N, Nishinaka Y, Herzenberg LA, and Yodoi J. Circulating thioredoxin suppresses lipopolysaccharide-induced neutrophil chemotaxis. Proc Natl Acad Sci U S A 98: 15143-15148, 2001.
25. Nakamura H, Matsuda M, Furuke K, Kitaoka Y, Iwata S, Toda K, Inamoto T, Yamaoka Y, Ozawa K, and Yodoi J. Adult T cell leukemia-derived factor/human thioredoxin protects endothelial F-2 cell injury caused by activated neutrophils or hydrogen peroxide. Immunol Lett 42: 75-80, 1994.
26. Oeverland B,Skatvedt O, Kvaerner KJ, and Akre H. Pulseoximetry: sufficient to diagnose severe sleep apnea. Sleep Med 3: 133-138, 2002.
27. Phillips B and Kryger MH. Management of obstructive sleep apnea-hypopnea syndrome: overview. In: Principles and Practice of Sleep Medicine, edited by Kryger MH, Roth T, and Dement WC. Philadelphia: Elsevier Saunders, 2005, pp. 1109-1121.
28. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, and Rimm EB. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 291: 1730-1737, 2004.
29. Rechtschaffen A and Kales A (Eds). A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. Washington, DC: National Institutes of Health, 1968.
30. Roux F, D'Ambrosio C, and Mohsenin V. Sleep-related breathing disorders and cardiovascular disease. Am J Med 108: 396-402, 2000.
31. Rubartelli A, Bajetto A, Allavena G, Wollman E, and Sitia R. Secretion of thioredoxin by normal and neoplastic cells through a leaderless secretory pathway. J Biol Chem 267: 24161-24164, 1992.
32. Schulz R, Mahmoudi S, Hattar K, Sibelius U, Olschewski H, Mayer K, Seeger W, and Grimminger F. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea: impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 162: 566-570, 2000.
33. Shamsuzzaman AS, Winnicki M, Lanfranchi P, Wolk R, Kara T, Accurso V, and Somers VK. Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 105: 2462-2464, 2002.
34. Shamsuzzaman AS, Gersh BJ, and Somers VK. Obstructive sleep apnea: implications for cardiac and vascular disease. JAMA 290: 1906-1914, 2003.
35. Sumida Y, Nakashima T, Yoh T, Furutani M, Hirohama A, Kakisaka Y, Nakajima Y, Ishikawa H, Mitsuyoshi H, Okanoue T, Kashima K, Nakamura H, and Yodoi J. Serum thioredoxin levels as a predictor of seatohepatitis in patients with nonalcoholic fatty liver disease. J Hepatol 38: 32-38, 2003.
36. Sumida Y, Nakashima T, Yoh T, Nakajima Y, Ishikawa H, Mitsuyoshi H, Sakamoto Y, Okanoue T, Kashima K, Nakamura H, and Yodoi J. Serum thioredoxin levels as an indicator of oxidative stress in patients with hepatitis C virus infection. J Hepatol 33: 616-622, 2000.
37. Svatikova A, Wolk R, Lerman LO, Juncos LA, Greene EL, McConnell JP, and Somers VK. Oxidative stress in obstructive sleep apnea. Eur Heart J 26: 2435-2439, 2005.
38. Tanne F, Gagnadoux F, Chazouilleres O, Fleury B, Wendum D, Lasnier E, Lebeau B, Poupon R, and Serfaty L. Chronic liver injury during obstructive sleep apnea. Hepatology 41: 1290-1296, 2005.
39. Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, and Tetaranni P. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86: 1930-1935, 2001.
40. Wolk R, Svatikova A, Nelson CA, Gami AS, Govender K, Winnicki M, and Somers VK. Plasma levels of adiponectin, a novel adipocyte-derived hormone, in sleep apnea. Obes Res 13: 186-190, 2005.
41. Yamauchi M, Nakano H, Maekawa J, Okamoto Y, Ohnishi Y, Suzuki T, and Kimura H. Oxidative stress in obstructive sleep apnea. Chest 127: 1674-1679, 2005.
42. Yokoe T, Minoguchi K, Matsuo H, Oda N, Minoguchi H, Yoshino G, Hirano T, and Adachi M. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 107: 1129-1134, 2003.
43. Young T, Skatrud J, and Peppard PE. Risk factors for obstructive sleep apnea in adults. JAMA 291: 2013-2016, 2004.